Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
This review provides an overview of the new and emerging drugs that are currently in clinical development for obesity, aiming to fill the gaps in the treatment options available
Triggered all-active metal organic framework: Ferroptosis machinery contributes to the apoptotic photodynamic antitumor therapy
Cagrilintide mimics the actions of amylin, a hormone made by the pancreas that helps you feel full after eating
Doses above 35mg/kg in rodent models show diminishing returns and increased off-target binding in hippocampal tissue studies
2014 Nov;24(6):629-33
US$ 20.46
US$ 25.21
US$ 20.38
